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INTRODUCTION 
On a recent trip to southern Brazil, Amigos, a non-profit organization 
providing vision care services via Pacific University College of Optometry, 
conducted a vision clinic for the individuals of Prudentopolis, Brazil. This 
team consisted of fifteen optometry students and two licensed optometrists 
who had a face-to-face experience with the devastation caused by ocular 
toxoplasmosis. Approximately 4.5% of the patients seen in the Amigo's clinic 
showed some evidence of either past or current ocular toxoplasmosis' 
complications. This was quite surprising considering that past studies 
indicate the incidence of ocular toxoplasmosis is significantly lower in other 
regions of the world (only 0.6% in the United States).l A study by Robert B. 
Nussenblatt, M.D., reported the incidence of ocular toxoplasmosis in 
southern Brazil to be 17.7% (thirty times higher than elsewhere in the 
world).2 In addition, a study done in southern Brazil in 1990, by Peter D. 
Glasner M.D. and fellow colleagues, found a significant incidence (17.7%) of 
ocular toxoplasmosis and a predominance of acquired cases rather than 
congenital) 
Because of the significant number of patients showing signs of 
toxoplasmosis, public health awareness would be beneficial to help decrease 
the risk of infection. An educational brochure was designed for the people of 
Prudentopolis, Brazil (Appendix A). This brochure, written in Portuguese 
and English, illustrates several methods by which individuals could adapt 
lifestyle changes to help decrease the risk of acquiring or transmitting 
toxoplasmosis gondii. Through heightened awareness, it is hoped that the 
future incidence of infestation and occurrence of ocular toxoplasmosis will 
decrease. 
The idea for a toxoplasmosis prevention program was conceived as 
"Team Brazil" began noticing the alarming number of patients with 
toxoplasmosis ocular infection. Although most cases were inactive, those 
patients with Toxoplasmosis gondii infection had significantly reduced 
visual acuities in the infected eye (Appendix C). 
Sixty of the 1,328 (4.5%) patients seen were positive for toxoplasma 
retinitis; a number much higher than the average found in the rest of the 
world, estimated to be only 0.6%.1 In addition, as an eye care team traveling 
in a foreign country, we experienced many living and social situations such as 
the increased diet of meat, very little hand washing, and raw meat exposed to 
the environment which promote the transmission of Toxoplasmosis gondii . 
On behalf of Amigos Eye Care, it was decided to make an effort towards 
decreasing the incidence of acquired and congenital toxoplasmosis in the area 
of Prudentopolis. An educational program consisting of both posters and 
pamphlets will be created and distributed in the town of Prudentopolis. Our 
~ope is to educate the citizens of Prudentopolis, and in turn, reduce the 
incidence of this sight robbing disease. 
AMIGOS TRIP- TEAM BRAZIL 
In March of 1997, seventeen Amigos Eye Care members from Pacific 
University College of Optometry traveled to Prudentopolis, Brazit to conduct 
a five-day vision care clinic. 
Exactly 1,328 patients received vision exams. A thorough case history 
was taken on each patient with the aid of translators, and both near and far 
visual acuities were taken, using Snellen distance charts and Lighthouse 
picture charts respectively. The team used a Retinomax autorefractor by 
Nikon to best estimate the patient's needed prescription and performed 
comprehensive ophthalmoscopy. Any abnormal finding demanded 
examination by one of the two attending doctors who prescribed medications 
for conjunctivitis and other diseases, dispensed ocular lubricants, educated 
patients on disease, and referred patients for cataract surgery. Dilated fundus 
exams and intraocular pressures were performed at this stage of the exam. 
Finally, after the doctors and interns were satisfied everything possible had 
been done for the patient's ocular status, the individual proceeded to the 
dispensary to receive, if needed, a pair of eyeglasses, previously donated to 
Amigos by optometrists and service organizations, such as Lion's Club and 
Kiwanis Club. 
During our exam of 1,328 patients (920 being hyperopes, 275 myopes 
and 133 emmetropes), the Amigos team found sixty people with ocular 
toxoplasmosis infection; twenty five males and thirty five females (Appendix 
A). Thirty of the hyperopes, twenty-four of the myopes, and six emmetropes 
had ocular toxoplasmosis. This gives an overall prevalence of ocular 
toxoplasmosis of 4.5%, with 5.1% in males and 4.2% in females. In addition, 
emmetropes had a 4.5% chance of having signs of ocular toxoplasmosis, and 
hyperopes had a 3.3% chance of having ocular toxoplasmosis. Of interesting 
note is that myopes showed an 8.7% ocular toxoplasmosis infection rate. 
TOXOPLASMOSIS: GENERAL OVERVIEW 
Toxoplasmosis is a disease of birds and mammals caused by the obligate 
intracellular protozoan known as Toxoplasmosis gondii. T. gondii affects 
approximately 500 million humans throughout the world.3 Although it is 
found in a large portion of the world's human population, relatively few 
people have the active disease, toxoplasmosis. Toxoplasmosis is a disease 
process with both systemic and ocular complications. Toxoplasmosis is not 
common in the United States (estimated to be 0.6%),1 yet has significant 
occurrence in countries where: 1) cat food is not processed, 2) there is little or 
no refrigeration of food, and 3) there is common practice of consumption of 
raw meat (particularly that which comes into contact with insects or cats).4 
Toxoplasmosis can be subdivided into two types: 1) congenital (infant 
infected in utero) and 2) acquired (through such means as ingestion of raw 
eggs, meat, or unpasteurized milk). The disease, whether acquired or 
congenitat may be in latent or recurring forms (under conditions of reduced 
host defenses, such as AIDS). The infection may be acute or chronic. The 
individual who has the T. gondii infection, may be symptomatic or 
asymptomatic. The disease has a kaleidescope of characteristics; the 
following are but a few of the systemic manifestations associated with the 
active disease: subclinical lymphadenopathy, malaise, maculapapular skin 
rash, hepatosplenomegaly, lymphacytosis, encephalitis, pneumonitis, and 
myocarditis. 5 
Of primary concern to optometrists is the devastating ocular 
presentations. The diagnosis of ocular toxoplasmosis is reliant on the 
presence of a characteristic retinal lesion in conjunction with the results of 
specified laboratory tests. The characteristic retinal lesion is typically a 
unilateral whitish yellow lesion (often with an associated adjacent area of 
inactive chorioretinal scar) with associated hazy vitreous ("headlights in the 
fog"). Other ocular manifestations may include vitreous precipitates and 
debris, optic disc edema, mild granulomatous iritis/uveitis, localized 
vasculitis, retinal artery or vein occlusion, chorioretinal scars, cystoid macular 
edema, visual field defects, and choroidal neovascular membrane.2 
Ocular toxoplasmosis is not a well understood disease. However, 
because of its devastating ocular involvement, it should be a concern to 
optometrists as primary eye care physicians. 
Toxoplasmosis is caused by an obligate intracellular parasite which is 
hosted primarily by the feline. However, it can infect and be hosted by almost 
any other mammal. Toxoplasmosis is present throughout the world, yet is 
more endemic to warm, humid climates.6 Because the organism, 
Toxoplasmosis gondii, is excreted from the cat in a form which remains 
viable for many months in the open environment, many mammals are 
susceptible to contact the oocysts found in soil, dirt, etc.6 It can also be 
transmitted via mother to fetus, via blood transfusion, via ingestion of 
undercooked meat, or via unpasteurized milk, lab accident and raw eggs.6 
Unfortunately, few studies have been conducted to enlighten the medical 
community concerning the reasons for the high prevalence of ocular 
toxoplasmosis in southern Brazil or on the means/methods possible to help 
prevent its infestation. 
TRANSMISSION OF TOXOPLASMOSIS GONDII 
The transmission of toxoplasmosis gondii can either be congenital or 
acquired. Most of the cases (80%) of toxoplasmosis are congenital. While 
ocular involvement is common, systemic involvement is rare. Concerning 
congenital toxoplasmosis, the incidence of fetal infection is related to the 
balance between the host and the parasite. This balance includes the maturity 
of the fetus 's immune system and the number and virulence of the parasites 
transmitted. Due to these factors, the age of the fetus at the time of infection 
determines the occurrence of congenital toxoplasmosis. The optimal 
conditions for transmission are the initial parasitemia that occurs before 
development of cellular immunity in the mother and a well-developed 
placental blood flow? This condition expresses itself when the primary 
infection occurs after week ten. 7 Although this conclusion has been made 
after numerous studies on animals as well as humans, congenital 
toxoplasmosis should be suspected in neonates of mothers who acquire the 
infection at any time during pregnancy.8 
Signs of the disease in neonates may include seizures, feeding 
problems, respiratory disease, and diarrhea.8 Extensive destruction may occur 
in the central nervous system causing damage in the cortex, mid brain, pons, 
medulla, and spinal cord. Obstruction of the foramina of Monro or the 
aqueduct of Sylvius can result in internal hydrocephalus. Maternal infection 
early in pregnancy is usually associated with fetal death or severe diseases at 
birth. Infection later in pregnancy typically results jn infants damaged at 
birth.3 Only 11% of maternal infections result in infants damaged at birth. It 
is stated that 60(Yo of infants are not affected, but 29% have subclinical 
infections that manifest as neurologic or sensory defects as the infant 
develops. Other complications may include spontaneous abortion, 
microcephalus, chorioretinitis, multiple organ involvement, and 
encephalitits.3 
The acquired form of toxoplasmosis is less frequent (20%) and tends to 
show more systemic involvement while ocular involvement is less 
prevalent. Acquired toxoplasmosis may be clinically silent in the normal 
host. In fact, 20-70% of American adults have immunoglobulin G antibodies 
to Toxoplasmosis gondii .9 The infection occurs by the ingestion of the tissue 
cysts in uncooked meat or ingestion of sporulated oocysts by hands or food 
contaminated by cat feces can cause inoculation. The capsule surrounding 
ingested cysts is digested by gastric juices; this permits viable trophozoites to 
invade intestinal mucosa and to disseminate throughout the body by way of 
blood and the lymphatics. Organ cell invasion produces foci of necrosis 
surrounded by intense inflammatory reaction with mononuclear cell 
infiltration. The spleen, liver, brain, lung, myocardium, and eye are most 
frequently involved.3 The development of cysts and tissue calcifications may 
impair organ functioning. An early antibody response destroys many 
parasites before they form tissue cysts and supports cyst formation by the 
remainder. The infection is typically limited to its mild or subclinical form 
for the majority of infected persons? 
In order to decrease transmission in the population, certain 
precautions should be taken. It is said that 25% of lamb and pork have been 
shown to contain tissue cysts. Beet unpasteurized goat milk, and eggs have 
also been said to contain the parasite.4 Improper hygiene practices such as 
uncovered food accessible to cockroaches and flies, as well as exposure to the 
feline population increases the risks of contracting toxoplasmosis. It is also 
important to realize that T. gondii can be transmitted by needle stick 
accidents involving blood, although this is rarely seen.3 
LIFE CYCLE OF TOXOPLASMOSIS GONDII 
There are many stages in the life cycle of the Toxoplasmosis gondii 
parasite including oocysts, sporozoites, bradyzoites (tissue cysts) and 
tachyzoites (trophozoites).9 
Tachyzoites are the invasive form of toxoplasmosis, causing acute 
infection. This is an obligate intracellular organismlO that invades every 
form of the mammalian celt with the exception of non-nucleated 
erythrocytes. The tachyzoites, crescent shaped and 2-3um X 6-7um in size, are 
ingested by a host, and move into the mammalian cells through either a 
mechanical or chemical process. Once inside the cell, the tachyzoite resides in 
vacuoles and multiplies via endodyogeny. In the tachyzoite form, the 
organism is susceptible to heat, freezing, and gastric secretions.9 
In order to survive in the human body over long periods of time, the 
tachyzoite transforms into a bradyzoite, the encysted form. In this form, the 
parasite is protected from immune response of the hosts . These cysts are 
responsible for latent infection, as they may rupture in the intestine walt and 
multiply as tachyzoites within the lamina propria, resulting in active retinitis 
especially in an immunocompromised host.9 
The oocyst, the sexual form of toxo, is 9-llum X 11-14um and contains 
four sporozoites.ll The oocyst is produced only in the cat. The cat 
accumulates bradyzoites or oocysts from eating infected raw meat, wild birds 
and mice; it then invades the epithelial cells of the eat's intestine and 
undergoes an entereoepithelial asexual cycle of division, known as 
schizogony. A sexual phase results, and the release of millions of oocysts 
occurs 3-21 days after ingestion. These oocysts undergo sporogony, forming 
four sporozoites, at which point they are considered infective. The oocytes 
are released into the environment via feces, and are viable for up to two 
years. Humans may be infected directly from the cat feces, or by ingesting the 
intermediate hosts of pork, mutton, beef, chicken, or eggs. Once inside the 
human, digestive enzymes disrupt the oocyst wall, and toxoplasmosis 
organisms, in the form of tachyzoites are released. The tachyzoites again 
cause active inflammation via reactions with the immune system.9 
DIAGNOSTIC TESTING FOR TOXOPLASMOSIS GONDII 
The diagnosis of toxoplasma retinitis is twofold, being based on both 
the presence of ocular lesion and confirmation by lab tests. Toxoplasmosis 
gondii must be differentially diagnosed with other causes of 
retinochoroiditis, such as sarcoidosis, tuberculosis, syphilis, and viral and 
fungal infections. In addition, if the toxo is believed to be congenital, 
differential diagnosis must be made with congenital herpes simplex virus, 
and cytomegalovirus.9 
There are numerous tests for the presence of Toxoplasmosis gondii in 
the human body; most are serologic, however these can be difficult to 
interpret as approximately 20-70% of the United States population is a carrier 
of toxoplasmosis gondii with only a few expressing any symptoms.9 
There are nine main tests for antibodies to toxoplasmosis in human 
blood: 
A. Serologic Tests 
1. Sabin-Fieldman Dye Test 
The standard for detection of Toxoplasmosis gondii antibodies, from 
which all other tests are evaluated. Live Toxoplasma is incubated with the 
sample serum. If anti-Toxoplasma antibody is present, no staining with 
methylene blue dye will occur, as the organisms cell membrane will be lysed 
and unable to hold the dye.9 
2. Indirect Fluorescent Antibody (IFA) Test 
The most widely used test, as it uses killed organisms, making it much 
safer for use in the human body. This test takes five days to show a positive 
result.9 
3. Indirect Hemagglutination Test 
This is a good screening test, but is not accurate for diagnosis, as it 
presents with many false-negatives. It is useful two to four weeks after acute 
infection, and involves red blood cells exposed to the antigen becoming 
sensitized to the appropriate antibody and agglutinating in the presence of 
that antibody.9 
4. Complement Fixation 
As a positive result does not necessarily indicate acute infection, nor a 
negative result ruling out past infection, this test is not recommended and is 
rarely used.9 
5. ELISA (Enzyme-Linked Immunosorbant Assay) test 
A very sensitive test that detects both IgG and IgM anti-toxoplasma 
antibodies in the blood. New versions utilize a double sandwich technique. 
eliminating many false positive results often caused by ANA and rheumatoid 
factor.9 
6. Aqueous Human Antibody 
This test is not used very often as it requires a paracentesis. It compares 
the ratio of anti-Toxoplasma antibodies in the aqueous humor with that in 
the serum. Specifically, 
[anti-toxo AB] compared to [ in serum] 
[gamma globulin in aqueous] 
note: [ ] denotes concentration 
A result of one-half to two indicates no infection; the presence of 
ocular toxoplasmosis is indicated by a number of eight of higher.9 
7. Toxoplasma Skin Test 
Very similar to the Tuberculosis PPD Mantou test, O.lml antigen from 
a mouse or chick is injected into the skin and the results are read at 48-72 
hours. If a induration of > lOmm in diameter is found, the test is considered 
positive.9 
B. Non-serologic Tests 
1. Mice inoculation 
Mice are injected with blood samples from the specimen and the 
mouse tissue is examined four weeks later for evidence of Toxoplasmosis 
gondii cysts or trophozoites.3 
2. Electron Microscope 
Tissue sections/smears from the specimen are examined under the 
electron microscope for trophozoites during the acute stages of infection.3 
TREATMENT OF TOXOPLASMOSIS GONDII 
Toxoplasmosis can be successfully treated. Success and opportunity 
varies with the individual (Appendix B). In immunocompentent people, 
toxoplasmosis is benign and self-limited and rarely requires treatment. In 
those who are immunocompromised in some way, toxoplasmosis can be life-
threatening. 
In particular, ocular toxoplasmosis treatment varies upon presentation. 
The decision to treat is based on the nature and location of the lesion on the 
retina. With infection, it is possible to get direct involvement of the fovea, 
papillomacular bundle, the optic nerve head, cystoid macular edema, and 
macular pucker.l2 Small peripheral lesions will usually heal spontaneously, 
while lesions in the posterior pole and large destructive lesions are treated 
regardless of location.9 Large impending lesions should receive all four drug 
therapies which will be discussed subsequently.l3 Depending on the point of 
time in the life-cycle, certain drug therapies can be effective. Particular drugs 
that will be discussed shortly have shown to be effective against the tachyzoite 
in animal models, but there is no success if the parasite has reached the 
bradyzoite stage?,9 
Although there is no set standard or consensus of the best drug therapy 
at the time of this writing, there are several drug combinations that are being 
used? Drug combinations may be synergistic, but at this time synergism has 
only been demonstrated for pyrimethamine and triple sulfa.l3 First, 
pyramethamine and sulfadiazine both interfere with folic acid metabolism. 
These two drugs basically accomplish the same task, but at different levels in 
the metabolic pathway. Pyrimethamine is either administered as a single oral 
loading dose of 75 mg or two loading doses of 50 mg 12 hours apart followed 
by a treatment of a dosage of 25 mg twice daily.9 Side effects of 
pyrimethamine are dose-related and reversible bone marrow suppression 
may occur in 12%. This suppression may result in anemia, leukopenia, or 
thrombocytopenia.l3 Gastrointestinal intolerance occurs in 50% of patients.9 
Sulfadiazine is administered as a single oral 2 gm loading dose followed by a 
treatment at a dosage of 1 gm 4 times daily. Side effects include skin rashes, 
crystalluria, albuniuria, and hematuria.12 If only one drug is chosen, it 
should be a trisulfapyrimidine because of its minimal expense, good 
tolerance, lack of spoilage, and simplicity of use.l3 Usual dosage is 1-1.5 gm 
given orally four times daily.l3 Clindamycin is also utilized alone or in a 
combination with pyramethamine and sulfadiazine. The dosage given is 300 
mg orally 4 times daily.l2 It does not cross the blood-brain barrier. Side 
effects include pseudomembranous colitis, which is reported to occur in 
anywhere from 1/50,000 to 1/100,000 cases.9 Patients should be instructed to 
discontinue use of the drug if they have four or more bowel movements per 
day than is normal for them.13 
Corticosteroids are also used to minimize the inflammatory response, 
but again, some type of antibiotic must be used synergistically to avoid 
infection due to the depression of the immune system. Systemic steroids are 
contraindicated in AIDS patients, although sub-Tenon's injections have 
proven to be quite safe.12 
Besides drug therapy, surgical treatment of toxoplasmosis is also 
available. Photocoagulation and cryotherapy may destroy Toxoplasma cysts as 
well as the tachyzoites. Photocoagulation does kill cysts of T. gondii, but it 
also damages normal retina and cannot be relied on to destroy all traces of T. 
gondii. Photocoagulation may be used when drug therapies have failed or if 
the patient cannot tolerate the medication.l3 The side effects of these 
particular treatments include retinal detachment, retinal hemorrhage, and 
vitreal hemorrhage.9 A subsequent vitrectomy may be required to remove 
vitreous opacities.12 Vitrectomy is only indicated for patients with dense 
membranes and extremely reduced vision.l3 
CONCLUSION 
It is hoped that through the distribution of the pamphlets to the people 
of Prudentopolis, Brazil, a reduction in both the prevalence and incidence of 
ocular toxoplasmosis infection will occur. With only a few minor lifestyle 
changes, it is believed the numbers can be lowered. 
Future studies may warrant further data collection in other parts of the 
world to determine if there is a direct correlation between cultural practices 
and hygiene to levels of ocular toxoplasmosis infection. In addition, further 
studies may investigate the prevalence of hyperopes with ocular 
toxoplasmosis infection, compared to the number of myopes with the 
infection. Our results showed a much higher percentage of myopes having 
toxoplasmosis as opposed to hyperopes. It would be interesting to determine 
if the myopia is a result of ocular toxoplasmosis infection, or if myopes are 
predisposed to the ocular infection. 
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Appendices 
Appendix A 
Toxoplasmosis gondii Pamphlet 
What is Toxoolasmosis? How To Prevent Toxoplasmosis Gondii Infection 
What your eye might see if you are 
injected with 'fDioplasmosis gondii 
Inside of your eye if you have an ocular 
Drink pasteurized milk 
Wash fruits and vegetables 
Toxoplasmosis gondii injection I Boil unclean drinking water 
. 
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.. / 
Cook your meat and eggs thoroughly 
Wash your hands well, especially after 
dealing with uncooked meat or soil 
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Wear gloves when working in the soil 
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Toxoplasmosis can be passed onto 
your unborn child! Expectant mothers 
should stay away from litter boxes, 
cats, rodents, and birds 
Keep animals out of children's play areas 
AppendixB 
VARYING TREATMENTS OF TOXOPLASMOSIS GONDII7/12 
Type of Infection Medication Dosage Duration of Therapy 
Pregnant women with acute Spiramycin 1 g every 8 hours without Until fetal infection 
toxoplasmosis (first 21 weeks food documented or excluded at 
of gestation or W1til term if 21 weeks; if documented, 
fetus not infected) in alternate months with 
pyrimethamine, 
leucovorin, and 
sulfadiazine 
Confirmed fetal infection 1. Pyrimethamine 1. Loading dose: 100 mg Same as above 
per day in two divided 
doses for 2 days then 50 
mgperday 
2. Sulfadiazine 2. Loading dose: 75 
mg/kg per day in two 
divided doses for 2 days, 
then 100 mg/kg per day in 
two divided doses 
(maximum 4 g per day) 
3. Leucovorin 3. 10-20 mg daily During and for 1 week 
(folinic acid) after pyrimethamine 
Congenital infection in the 1. Pyrimethamine 1. Loading dose: 2 mg/kg 1. 1 year 
infant per day for 2 days, then 1 
mg/kg per day for 2 or 6 
months, then this dose 
every Monday, 
Wednesday, Friday 
2. Sulfadiazine 2. 100 mg/kg per day in 2. 1 year 
two divided doses 
3. Leucovorin 3. 10 mg three times 3. During and for 1 week 
weekly after pyrimethamine 
4. Corticosteroids 4. 1 mg/kg per day in two 4. Until resolution of 
divided doses elevated CSF protein 
level or active 
chorioretinitis that 
threatens vision 
Active chorioretinitis in 1. Pyrimethamine 1. Loading dose: 2 mg/kg 1. Usually 1-2 weeks 
older children per day (maxirnwn 50 mg) beyond the time that 
for 2 days, then signs and symptoms have 
maintenance, 1 mg/kg per resolved 
day (maximum 25 mg) 
2. Sulfadiazine 2. Loading dose: 75 2. Usually 1-2 weeks 
mg/kg, then beyond the time that 
maintenance, 50 mg/kg signs and symptoms have 
every 12 hours resolved 
3. Leucovorin 3. 10-20 mg three times 3. During and for 1 week 
weekly after pyrimethamine 
therapy 
4. Corticosteroids 4. 1 mg/kg per day in two 4. Until resolution of 
divided doses elevated CSF fluid 
protein level or active 
chorioretinitis that 
threatens vision 
Ocular toxoplasmosis 1. Pyrimethamine 1. Two 50 mg loading 3-4 weeks 
doses 12 hours apart, then 
25 mg by mouth twice 
daily 
2. Sulfadiazine 2. 2 gm loading dose, then 
1 gm by mouth four times 
daily 
3. Folinic Acid 3. 3-5 mg by mouth twice 
weekly 
4. Prednisone 4. 20-40 mg by mouth once 
daily 
General Numbers Tested 
Total Hyperopes = 920 
Total Myopes = 275 
AppendixC 
Total Emmetropes = 133 (all based on OD refraction) 
Total tested= 1328 
Total Males tested= 484 
Total Females tested = 841 (note: total males and females only equals 1325 as three sexes were not 
recorded. For stats purposes, 1 will be added to 484 and 2 to 841 to 
result in the 1328 patients. This is based on the 2:1 female to male 
patient ratio). 
Prevalence of Toxoplasmosis in Prudentopolis Brazil 
Toxo in OD = 42 
42 cases/1328 = 3.6% (36 per 1000) 
Toxo in OS= 28 
28 cases/1328 = 2.1% (21 per 1000) 
Toxo in OU = 10 
10 cases/1328 = 0.75% (7.5 per 1000) 
Total prevalence [(OD+OS)-OU]/1328 = 4.5% (45 per 1000) 
Males with toxo = 25 
25/485 = 5.1% (51 per 1000 males) 
Females with toxo = 35 
35/843 = 4.2% (42 per 1000 females) 
# hyperopes with ocular toxo (based on OD refraction)= 30 
30/920 = 3.3% (33 per 1000 hyperopes) 
30/1328 = 2.3% (23 per 1000 in general population) 
# myopes with ocular toxo (based on OD refraction) = 24 
24/275 = 8.7% (87 per 1000 myopes) 
24/1328 = 1.8% (18 per 1000 in general population) 
# emmetropes with ocular toxo (based on OD refraction) = 6 
6/133 = 4.5% (45 per 1000 emmetropes) 
6/1328 = 0.45% (4.5 per 1000 in general population) 
Appendix C continued 
StatView Summary of Prudentopolis Data 
age sex vaod va os toxo.od toxo.os rx.od rx.os 
Mean 42.891 1.635 125.28 124.93 .032 .021 .756 .81 
Std. Deviation 17.607 0.482 387.17 3'80.39 .175 .144 1.546 1.70 
:tvlinimum 4 1 0.00 0.00 0 0 -8.750 -16.25 
Maximum 87 2 2000 2000 1 1 11.250 14.75 
Rooge 83.000 1 2000 2000 1.000 1.000 20.000 31.00 
Count 1319 1327 1328 1328 1328 1328 1304 1317 
Sum 56573 2169 166376 165906 42 28 98 1061 
where: Sex l=male 2=female 
VA 20/# (snellen) 
Toxo 1=present O=none 
